ARCHIVES

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 32 | September 4, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

Funding Opportunities.

April 12, 2002

Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.

January 25, 2002

“Withheld” News Release On QRA Policies Released

November 11, 1983

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Funding opportunities listed.

November 19, 2004